483
Allergan Sales, LLCFDA 483 - Allergan Sales, LLC - July 09, 2010
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Allergan Inc. in Irvine, CA, from July 6-9, 2010, identified three observations. The firm failed to timely report serious and unexpected adverse drug experiences and did not submit annual periodic adverse drug experience reports or other annual reports within the required timeframes.
Open in Dashboard
ID · dc2754a0-383b-4aca-b94a-0cc7b5d6a4cb